MORE►
beth shapiro
The bluebuck became extinct just 34 years after it was first scientifically documented. [Image: Colossal]
Colossal Targets Extinct Antelope—and Adds a New Branch to its De-Extinction ‘Tree of Life’
by Quincy Preston | Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
by Quincy Preston |
Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by David Seeley |
Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE►
by Lance Murray |
Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE►
Romulus and Remus, shown here at three months, turned six months old in April. The twin male dire wolves are the world’s first successfully de-extinct animals. Born from ancient DNA and modern science, they now roam a secure preserve in an ice age comeback story. [Photo: Colossal]
Hear the Howl: Dallas De‑Extinction Company Colossal Biosciences Brings Back Dire Wolf Using Ancient DNA
by Quincy Preston | Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE►
by Quincy Preston |
Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Nov 21, 2024
“As bird species disappear, we lose key components of ecosystems, including pollinators, insectivores, and spreaders of seeds, with negative impacts for both human and planetary health," said Colossal co-founder and CEO Ben Lamm.
MORE►
by David Seeley |
Mar 29, 2024
Long's Austin-based Re:wild and Dallas-based Colossal Biosciences have announced a new partnership to accelerate global efforts "to save species on the brink of extinction, search for lost species, and restore key habitats for species recovery and rewilding."
MORE►
